Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial

Background: Worldwide, millions of women seek treatment for early pregnancy loss (EPL) annually. Medical management with misoprostol is widely used, but only effective 60% of the time. Pre-treatment with mifepristone prior to misoprostol might improve the success rate of medical management. Methods:...

Full description

Bibliographic Details
Main Authors:	Charlotte Hamel, Sjors Coppus, Joyce van den Berg, Esther Hink, Jacoba van Seeters, Paul van Kesteren, Ashley Merién, Bas Torrenga, Rafli van de Laar, Josien Terwisscha van Scheltinga, Ingrid Gaugler-Senden, Peppino Graziosi, Minouche van Rumste, Ewka Nelissen, Frank Vandenbussche, Marcus Snijders
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	EClinicalMedicine
Subjects:	Early pregnancy loss Mifepristone Misoprostol
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537020304600

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020304600

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial

Internet

Similar Items